Sfoglia per Autore
Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
2019-01-01 Plantone, D; Inglese, M; Salvetti, M; Koudriavtseva, T
Tumefactive Demyelinating Lesions and Pregnancy
2019-01-01 Plantone, D; Piantadosi, C; Ruggieri, S; Anelli, V; Koudriavtseva, T
A Neurometabolic Profile of Secondary Progressive Multiple Sclerosis: The Relationship between Brain Metabolites and Clinical Disability
2019-01-01 John, Na; Solanky, B; De Angelis, F; Stutters, J; Prados, F; Plantone, D; Monteverdi, A; Doshi, A; Macmanus, D; Wheeler-Kingshott, Camg; Barkhof, F; Chataway, J
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review
2018-01-01 Plantone, D; Koudriavtseva, T.
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview
2018-01-01 De Angelis, F; Plantone, D; Chataway, J
Striatum Involvement in LGI1 Limbic Encephalitis
2018-01-01 Plantone, D
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
2018-01-01 Connick, P; De Angelis, F; Parker, Ra; Plantone, D; Doshi, A; John, N; Stutters, J; Macmanus, D; Prados Carrasco, F; Barkhof, F; Ourselin, S; Braisher, M; Ross, M; Cranswick, G; Pavitt, Sh; Giovannoni, G; Gandini Wheeler-Kingshott, Ca; Hawkins, C; Sharrack, B; Bastow, R; Weir, Cj; Stallard, N; Chandran, S; Chataway, J; UK Multiple Sclerosis Society Clinical Trials, Network.
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis
2018-01-01 Cawley, N; Tur, C; Prados, F; Plantone, D; Kearney, H; Abdel-Aziz, K; Ourselin, S; Wheeler-Kingshott, Cag; Miller, Dh; Thompson, Aj; Ciccarelli, O.
A neurometabolic profile of SPMS: the relationship between brain metabolites and clinical disability
2018-01-01 John, N; Solanky, B; Deangelis, F; Stutters, J; Prados, F; Plantone, D; Tur, C; Doshi, A; Monteverdi, A; Macmanus, D; Ourselin, S; Pavitt, S; Giovannoni, G; Parker, R; Weir, Cj; Stallard, N; Hawkins, Cp; Sharrack, B; Connick, P; Chandran, S; Wheeler-Kingshott, C; Barkhof, F; Chataway, J
Retinal nerve fibre layer thickness in the temporal quadrant predicts clinical disability and cervical cord cross sectional area in secondary progressive multiple sclerosis
2018-01-01 De Angelis, F; Garcia, A; Stutters, J; Eshaghi, A; Parker, R; Plantone, D; Doshi, A; John, N; Calvi, A; Prados, F; Macmanus, D; Wheeler-Kingshott, Camg; Weir, Cj; Chandran, S; Barkhof, F; Chataway, J
Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis
2018-01-01 Doshi, A; De Angelis, F; Muhlert, N; Stutters, J; Eshaghi, A; Prados, F; Plantone, D; John, N; Calvi, A; Macmanus, D; Ourselin, S; Pavitt, S; Giovannoni, G; Parker, R; Weir, Cj; Stallard, N; Hawkins, Cp; Sharrack, B; Connick, P; Chandran, S; Wheeler-Kingshott, Cag; Ciccarelli, O; Barkhof, F; Chataway, J
Spinal cord area is a stronger predictor of physical disability than brain volume in secondary progressive Multiple Sclerosis
2018-01-01 De Angelis, F; Stutters, J; Eshaghi, A; Garcia, A; Prados, F; Plantone, D; Doshi, A; John, Na; Calvi, A; Macmanus, D; Ourselin, S; Pavitt, S; Giovannoni, G; Parker, R; Weir, Cj; Stallard, N; Hawkins, Cp; Sharrack, B; Connick, P; Chandran, S; Wheeler-Kingshott, Cag; Barkhof, F; Chataway, J
Systematic assessment and characterization of chronic pain in multiple sclerosis patients
2018-01-01 Ferraro, D; Plantone, D; Morselli, F; Dallari, G; Simone, Am; Vitetta, F; Sola, P; Primiano, G; Nociti, V; Pardini, M; Mirabella, M; Vollono, C.
HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence
2017-01-01 Koudriavtseva, T; Plantone, D; Mandoj, C; Giannarelli, D; Latini, A; Colafigli, M; Trento, E; Cordiali-Fei, P; Pimpinelli, F
Neuroradiological characterization of multiple sclerosis patients with chronic pain
2017-01-01 Plantone, D; Ferraro, D; Vitetta, F; Simone, Am; Myftari, V; Sola, P; Mirabella, M; Primiano, G; Pardini, M; Vollono, C
Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS
2017-01-01 De Angelis, F; Gomez, Ag; Parker, R; Plantone, D; Doshi, A; Barkhof, F; Stutters, J; Miller, Dh; Pavitt, Sh; Giovannoni, G; Wheeler-Kingshott, Cg; Weir, C; Connick, P; Stallard, N; Hawkins, C; Sharrack, B; Chandran, S; Chataway, J
HIV and lower risk of multiple sclerosis: role of adaptive immune response
2016-01-01 Koudriavtseva, T; Plantone, D; Renna, R; Latini, A; Colafigli, M; Mandoj, C; Trento, E; Pimpinelli, F
Dimethyl fumarate may still have a role in progressive multiple sclerosis
2016-01-01 Plantone, D; De Angelis, F; Doshi, A; Chataway, J
Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations
2016-01-01 Koudriavtseva, T; Plantone, D
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis
2016-01-01 Yiannakas, Mc; Mustafa, Am; De Leener, B; Kearney, H; Tur, C; Altmann, Dr; De Angelis, F; Plantone, D; Ciccarelli, O; Miller, Dh; Cohen-Adad, J; Gandini Wheeler-Kingshott, Ca.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis | 1-gen-2019 | Plantone, D; Inglese, M; Salvetti, M; Koudriavtseva, T | - | |
| Tumefactive Demyelinating Lesions and Pregnancy | 1-gen-2019 | Plantone, D; Piantadosi, C; Ruggieri, S; Anelli, V; Koudriavtseva, T | - | |
| A Neurometabolic Profile of Secondary Progressive Multiple Sclerosis: The Relationship between Brain Metabolites and Clinical Disability | 1-gen-2019 | John, Na; Solanky, B; De Angelis, F; Stutters, J; Prados, F; Plantone, D; Monteverdi, A; Doshi, A; Macmanus, D; Wheeler-Kingshott, Camg; Barkhof, F; Chataway, J | - | |
| Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review | 1-gen-2018 | Plantone, D; Koudriavtseva, T. | - | |
| Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview | 1-gen-2018 | De Angelis, F; Plantone, D; Chataway, J | - | |
| Striatum Involvement in LGI1 Limbic Encephalitis | 1-gen-2018 | Plantone, D | - | |
| Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis | 1-gen-2018 | Connick, P; De Angelis, F; Parker, Ra; Plantone, D; Doshi, A; John, N; Stutters, J; Macmanus, D; Prados Carrasco, F; Barkhof, F; Ourselin, S; Braisher, M; Ross, M; Cranswick, G; Pavitt, Sh; Giovannoni, G; Gandini Wheeler-Kingshott, Ca; Hawkins, C; Sharrack, B; Bastow, R; Weir, Cj; Stallard, N; Chandran, S; Chataway, J; UK Multiple Sclerosis Society Clinical Trials, Network. | - | |
| Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis | 1-gen-2018 | Cawley, N; Tur, C; Prados, F; Plantone, D; Kearney, H; Abdel-Aziz, K; Ourselin, S; Wheeler-Kingshott, Cag; Miller, Dh; Thompson, Aj; Ciccarelli, O. | - | |
| A neurometabolic profile of SPMS: the relationship between brain metabolites and clinical disability | 1-gen-2018 | John, N; Solanky, B; Deangelis, F; Stutters, J; Prados, F; Plantone, D; Tur, C; Doshi, A; Monteverdi, A; Macmanus, D; Ourselin, S; Pavitt, S; Giovannoni, G; Parker, R; Weir, Cj; Stallard, N; Hawkins, Cp; Sharrack, B; Connick, P; Chandran, S; Wheeler-Kingshott, C; Barkhof, F; Chataway, J | - | |
| Retinal nerve fibre layer thickness in the temporal quadrant predicts clinical disability and cervical cord cross sectional area in secondary progressive multiple sclerosis | 1-gen-2018 | De Angelis, F; Garcia, A; Stutters, J; Eshaghi, A; Parker, R; Plantone, D; Doshi, A; John, N; Calvi, A; Prados, F; Macmanus, D; Wheeler-Kingshott, Camg; Weir, Cj; Chandran, S; Barkhof, F; Chataway, J | - | |
| Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis | 1-gen-2018 | Doshi, A; De Angelis, F; Muhlert, N; Stutters, J; Eshaghi, A; Prados, F; Plantone, D; John, N; Calvi, A; Macmanus, D; Ourselin, S; Pavitt, S; Giovannoni, G; Parker, R; Weir, Cj; Stallard, N; Hawkins, Cp; Sharrack, B; Connick, P; Chandran, S; Wheeler-Kingshott, Cag; Ciccarelli, O; Barkhof, F; Chataway, J | - | |
| Spinal cord area is a stronger predictor of physical disability than brain volume in secondary progressive Multiple Sclerosis | 1-gen-2018 | De Angelis, F; Stutters, J; Eshaghi, A; Garcia, A; Prados, F; Plantone, D; Doshi, A; John, Na; Calvi, A; Macmanus, D; Ourselin, S; Pavitt, S; Giovannoni, G; Parker, R; Weir, Cj; Stallard, N; Hawkins, Cp; Sharrack, B; Connick, P; Chandran, S; Wheeler-Kingshott, Cag; Barkhof, F; Chataway, J | - | |
| Systematic assessment and characterization of chronic pain in multiple sclerosis patients | 1-gen-2018 | Ferraro, D; Plantone, D; Morselli, F; Dallari, G; Simone, Am; Vitetta, F; Sola, P; Primiano, G; Nociti, V; Pardini, M; Mirabella, M; Vollono, C. | - | |
| HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence | 1-gen-2017 | Koudriavtseva, T; Plantone, D; Mandoj, C; Giannarelli, D; Latini, A; Colafigli, M; Trento, E; Cordiali-Fei, P; Pimpinelli, F | - | |
| Neuroradiological characterization of multiple sclerosis patients with chronic pain | 1-gen-2017 | Plantone, D; Ferraro, D; Vitetta, F; Simone, Am; Myftari, V; Sola, P; Mirabella, M; Primiano, G; Pardini, M; Vollono, C | - | |
| Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS | 1-gen-2017 | De Angelis, F; Gomez, Ag; Parker, R; Plantone, D; Doshi, A; Barkhof, F; Stutters, J; Miller, Dh; Pavitt, Sh; Giovannoni, G; Wheeler-Kingshott, Cg; Weir, C; Connick, P; Stallard, N; Hawkins, C; Sharrack, B; Chandran, S; Chataway, J | - | |
| HIV and lower risk of multiple sclerosis: role of adaptive immune response | 1-gen-2016 | Koudriavtseva, T; Plantone, D; Renna, R; Latini, A; Colafigli, M; Mandoj, C; Trento, E; Pimpinelli, F | - | |
| Dimethyl fumarate may still have a role in progressive multiple sclerosis | 1-gen-2016 | Plantone, D; De Angelis, F; Doshi, A; Chataway, J | - | |
| Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations | 1-gen-2016 | Koudriavtseva, T; Plantone, D | - | |
| Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis | 1-gen-2016 | Yiannakas, Mc; Mustafa, Am; De Leener, B; Kearney, H; Tur, C; Altmann, Dr; De Angelis, F; Plantone, D; Ciccarelli, O; Miller, Dh; Cohen-Adad, J; Gandini Wheeler-Kingshott, Ca. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile